News
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...
A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...
State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so. Meanwhile, Medicare currently covers GLP-1 drugs for people with a ...
When I wrote about intermittent fasting in The Fast Diet with the late Michael Mosley in 2012, we often stated, sagely and ...
Combination therapy with cagrilintide and semaglutide vs cagrilintide alone, semaglutide alone, and placebo is superior for improving weight loss results.
When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...
13h
MedPage Today on MSNJustin Timberlake's Diagnosis; Senate Defies Trump on NIH; CMS' Wegovy Coverage PlanNote that some links may require registration or subscription. Justin Timberlake said he has been diagnosed with Lyme disease ...
The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...
10h
EatingWell on MSN7-Day Diabetes-Friendly Meal Plan with 30-Minute Dinners, Created by a DietitianThis 7-day plan is set at 1,800 calories, with modifications for 1,500 and 2,000 calories per day. Each day provides at least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results